AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇳🇬
Oxaliplatin in Nigeria
5 products registered with NAFDAC — 4 active, 1 expired
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| VSI Oxaliplatin Injection Injection | B4-3208 | Manola Pharmaceuticals Limited | active | 27 Aug 2029 |
| Oxaliplatin Sandoz Concentrate For Solution For Infusion Solution for injection/infusion | C4-2026 | Novartis Nigeria Limited | active | 21 Oct 2027 |
| Eloxatin Infusion Solution for infusion | A4-2102 | Sanofi-Aventis Nigeria Limited | active | 25 Aug 2026 |
| Celdach 100 Injection** Powder for infusion | A4-4792 | L'PaceMaker Pharmaceuticals Limited | active | 23 Jun 2026 |
| OXALIPLATIN SANDOZ 5MG/ML POWDER FOR SOLUTION FOR INFUSION/ 1 X 1 VIAL | B4-7136 | NORVATIS NIG. LTD. MANSARD PLACE | expired | 3 Jul 2022 |
Oxaliplatin — NAFDAC Registration Details
NAFDAC (Nigeria) has 5 registered products containing Oxaliplatin, of which 4 are currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.
Track Oxaliplatin registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.